JP Morgan Private Wealth Advisors’s Pulse Biosciences PLSE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-48,000
Closed -$73K 1966
2022
Q2
$73K Hold
48,000
﹤0.01% 1886
2022
Q1
$233K Hold
48,000
﹤0.01% 1854
2021
Q4
$711K Hold
48,000
﹤0.01% 1402
2021
Q3
$1.04M Hold
48,000
﹤0.01% 1189
2021
Q2
$787K Hold
48,000
﹤0.01% 1302
2021
Q1
$1.14M Sell
48,000
-3,856
-7% -$115K ﹤0.01% 982
2020
Q4
$1.24M Buy
51,856
+1,533
+3% +$24.4K ﹤0.01% 924
2020
Q3
$593K Hold
50,323
﹤0.01% 1088
2020
Q2
$526K Buy
50,323
+7,723
+18% +$69.5K ﹤0.01% 1067
2020
Q1
$305K Buy
+42,600
New +$442K ﹤0.01% 1133

Other funds holding PLSE

JP Morgan Private Wealth Advisors's PLSE Position: Q3 2022 in Review

JP Morgan Private Wealth Advisors sold out of Pulse Biosciences (PLSE) in Q3 2022, closing a stake of 48,000 shares — an estimated $73K sold.

JP Morgan Private Wealth Advisors first reported a position in PLSE in Q1 2020 and held it in 10 quarters. The position peaked at $1.24M in Q4 2020. 31 funds tracked by Wall St. Rank hold PLSE as of Q3 2022.

  • JP Morgan Private Wealth Advisors reported no remaining Pulse Biosciences position as of Q3 2022 after selling out during the quarter.
  • JP Morgan Private Wealth Advisors sold 48,000 Pulse Biosciences shares in Q3 2022, an estimated $73K.
  • JP Morgan Private Wealth Advisors first reported a position in Pulse Biosciences in Q1 2020 and held it in 10 quarters.
  • JP Morgan Private Wealth Advisors's Pulse Biosciences position peaked at $1.24M in Q4 2020.
  • 31 funds tracked by Wall St. Rank held Pulse Biosciences as of Q3 2022.

Based on JP Morgan Private Wealth Advisors's 13F filing for Q3 2022, filed 4 Nov 2022.